Skip to main content

Table 4 Comparison of women (n = 77) and men (n = 85) on frequency of laboratory abnormalities: laboratory reports, self-reports, and patient awareness

From: HIV or HIV-Therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV

  Laboratory reportSelf-report Awareness†    
Laboratory abnormality Women
(%)
Men
(%)
Women
(%)
Men
(%)
Women
(%)
Men
(%)
Anemia       
   Grade 1 18 12 1 0 7 0
Renal parameter††       
   Grade 1 7** 25** 0 0 0 0
Liver parameter††† 55 68 21 16 38 23
   Grade 1 42 54 13 10 31 18
   Grade 2 9 11 5 4 56 36
   Grade 3 4 4 3 2 75 50
Hyperglycemia 12 14 0 1 0 8
   Grade 1 8 10 0 0 0 0
   Grade 2 3 0 0 0 0 0
   Grade 3 1 4 0 1 0 50
Elevated Lipids†††† 55 66 11 15 20 23
   Grade 1 47 54 8 10 17 18
   Grade 2 8 10 3 5 38 50
   Grade 3 - 2 - 1 - 50
Lactic Acidosis†††††       
   Grade 1 8 19 0 0 0 0
  1. † Awareness refers to the percentage of laboratory abnormalities that were patient-reported
  2. †† Abnormality in at least one renal parameter (creatinine, urea, uric acid, electrolytes)
  3. ††† Abnormality in at least one liver parameter (ALT, AST, ALP, GGT, bilirubine -except for benign hyperbilirubinemea under Atazanavir or Indinavir)
  4. †††† Abnormality in at least one lipid parameter (triglycerides, LDH, HDLH, total cholesterol)
  5. ††††† Physician reports are only available on 13 women and 21 men.
  6. Chi square test indicates significant difference between men and women at:
  7. *p < .05 and**p < .01